Concepedia

Robert S. Goodwin

RS

Statistics

Publications

34

Citations

5.3K

H-Index

26

Active since

1974

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

University of Maryland, Baltimore

National Institute of Mental Health

Institute of Forensic Sciences

Robert S. Goodwin is an author at National Institute on Drug Abuse specializing in pharmacology, cannabinoid pharmacology, and pharmacokinetics.

Publications per year

1974–2015

34

Publications

34

Controlled Sedation with Alphaxalone-Alphadolone

Michael A. E. Ramsay, T.M. Savege, B. R. Simpson et al. · BMJ · 1974 · 2.9K citations · Full text

, , +13

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

Jussi Hirvonen, Robert S. Goodwin, Cheng‐Ta Li et al. · Molecular Psychiatry · 2011 · 584 citations

, , +13

Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration

Erin L Karschner, W. D. Darwin, Robert S. Goodwin et al. · Clinical Chemistry · 2010 · 226 citations · Full text

, , +12

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws

Mateus M. Bergamaschi, Erin L Karschner, Robert S. Goodwin et al. · Clinical Chemistry · 2013 · 152 citations · Full text

, , +16

Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults

Erin A Kolbrich, Robert S. Goodwin, David A. Gorelick et al. · Therapeutic Drug Monitoring · 2008 · 127 citations · Full text

, , +12

1–5 of 34